Associate Professor of Medicine, Harvard Medical School. Expert in drug discovery. Board member of Famygen, which was recently acquired by Viatris for over $300M
He brings 30+ years of experience in biotech, pharma and CPG, Has led and scaled $1+ billion companies in the healthcare / life sciences space. Ex-CEO at Emami, a $2.5B company.
She has served as patent counsel, including in leadership roles, at Colgate and BMS
He is founder partner of Remus Capital. He is a contrarian investor and led investments into category-leading companies including Presto (NASDAQ: PRST; he is Chairman), Allurion Technologies (NYSE: ALUR)
He is a founding partner at Iron Pillar. Mohanjit served as a Partner at Draper Fisher Jurvetson for 9 years, coordinating business development efforts with Fortune 500 companies for DFJ's global portfolio.
He is managing director of Navam Capital, a venture investment firm, focusing on early-stage deep tech ventures. Prior to founding Navam Capital, Rajeev worked as a venture capitalist at venture capital fund Lux Capital in New York City
Copyright © 2024 Vyome Therapeutics, Inc. All rights reserved.
Developed by Kenovate Solutions